Dr Axel Walter, Consultant Medical Oncologist at Bristol Haematology and Oncology Center, kicks off the series about how to manage ovarian cancer. He discusses in depth the staging system and how women with initial ovarian cancer should be treated, including both those with stage 1 and stage 3 disease. This includes an explanation regarding BRCA and HRD (homologous recombination deficiency) testing and treatment with adjuvant PARP inhibitors.

Your host is Dr Alison Cameron, Bristol, UK.